Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-19

Clinical Trial Update: A Trial of SHR-1139 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial of SHR-1139 in healthy volunteers; psoriasis is listed as a condition but participants are healthy, and the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHR-1139

Snippet

Sponsor: Atridia Pty Ltd. | Conditions: Psoriasis | Phase 1 | Status: ACTIVE_NOT_RECRUITING